1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
SER 32 - ASP 33 MODEL 1 OMEGA =218.49 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
SER 32 - ASP 33 MODEL 10 OMEGA =215.83 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
SER 32 - ASP 33 MODEL 15 OMEGA =219.86 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
Szyperski, T.
Guntert, P.
Stone, S.R.
Wuthrich, K.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
UK
J.Mol.Biol.
JMOBAK
0070
0022-2836
228
1193
1205
10.1016/0022-2836(92)90325-E
1335515
Nuclear magnetic resonance solution structure of hirudin(1-51) and comparison with corresponding three-dimensional structures determined using the complete 65-residue hirudin polypeptide chain.
1992
UK
J.Mol.Biol.
JMOBAK
0070
0022-2836
228
1206
Impact of Protein-Protein Contacts on the Conformation of Thrombin-Bound Hirudin Studied by Comparison with the NMR Solution Structure of Hirudin(1-51)
1992
US
Biochemistry
BICHAW
0033
0006-2960
28
4301
Conformation of Recombinant Desulfatohirudin in Aqueous Solution Determined by Nuclear Magnetic Resonance
1989
US
Biochemistry
BICHAW
0033
0006-2960
28
2601
Solution Structure of Recombinant Hirudin and the Lys 47-Glu Mutant: A Nuclear Magnetic Resonance and Hybrid Geometry-Dynamical Simulated Annealing Study
1989
10.2210/pdb1hic/pdb
pdb_00001hic
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
5293.813
HIRUDIN VARIANT
1
man
polymer
no
no
VVYTDCTESGQNLCLCEGSNVCGQGNKCILGSDGEKNQCVTGEGTPKPQSH
VVYTDCTESGQNLCLCEGSNVCGQGNKCILGSDGEKNQCVTGEGTPKPQSH
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
medicinal leech
Hirudo
sample
6421
Hirudo medicinalis
database_2
pdbx_database_status
pdbx_nmr_software
pdbx_struct_assembly
pdbx_struct_oper_list
repository
Initial release
Version format compliance
Version format compliance
Data collection
Database references
Derived calculations
Other
1
0
1994-01-31
1
1
2008-03-24
1
2
2011-07-13
1
3
2022-02-23
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_database_status.process_site
_pdbx_nmr_software.name
Y
BNL
1992-04-30
REL
REL
20
GUNTERT,BRAUN,WUTHRICH
refinement
DIANA
SINGH,WEINER,CALDWELL,KOLLMAN
refinement
Amber
3.0
VAL
1
n
1
VAL
1
A
VAL
2
n
2
VAL
2
A
TYR
3
n
3
TYR
3
A
THR
4
n
4
THR
4
A
ASP
5
n
5
ASP
5
A
CYS
6
n
6
CYS
6
A
THR
7
n
7
THR
7
A
GLU
8
n
8
GLU
8
A
SER
9
n
9
SER
9
A
GLY
10
n
10
GLY
10
A
GLN
11
n
11
GLN
11
A
ASN
12
n
12
ASN
12
A
LEU
13
n
13
LEU
13
A
CYS
14
n
14
CYS
14
A
LEU
15
n
15
LEU
15
A
CYS
16
n
16
CYS
16
A
GLU
17
n
17
GLU
17
A
GLY
18
n
18
GLY
18
A
SER
19
n
19
SER
19
A
ASN
20
n
20
ASN
20
A
VAL
21
n
21
VAL
21
A
CYS
22
n
22
CYS
22
A
GLY
23
n
23
GLY
23
A
GLN
24
n
24
GLN
24
A
GLY
25
n
25
GLY
25
A
ASN
26
n
26
ASN
26
A
LYS
27
n
27
LYS
27
A
CYS
28
n
28
CYS
28
A
ILE
29
n
29
ILE
29
A
LEU
30
n
30
LEU
30
A
GLY
31
n
31
GLY
31
A
SER
32
n
32
SER
32
A
ASP
33
n
33
ASP
33
A
GLY
34
n
34
GLY
34
A
GLU
35
n
35
GLU
35
A
LYS
36
n
36
LYS
36
A
ASN
37
n
37
ASN
37
A
GLN
38
n
38
GLN
38
A
CYS
39
n
39
CYS
39
A
VAL
40
n
40
VAL
40
A
THR
41
n
41
THR
41
A
GLY
42
n
42
GLY
42
A
GLU
43
n
43
GLU
43
A
GLY
44
n
44
GLY
44
A
THR
45
n
45
THR
45
A
PRO
46
n
46
PRO
46
A
LYS
47
n
47
LYS
47
A
PRO
48
n
48
PRO
48
A
GLN
49
n
49
GLN
49
A
SER
50
n
50
SER
50
A
HIS
51
n
51
HIS
51
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
N
CYS
14
A
N
CYS
14
A
O
CYS
22
A
O
CYS
22
A
O
ILE
29
A
O
ILE
29
A
N
GLN
38
A
N
GLN
38
1
A
A
SER
ASP
32
33
-141.51
10
A
A
SER
ASP
32
33
-144.17
15
A
A
SER
ASP
32
33
-140.14
7
A
TYR
3
0.067
SIDE CHAIN
11
A
TYR
3
0.070
SIDE CHAIN
17
A
TYR
3
0.079
SIDE CHAIN
19
A
TYR
3
0.072
SIDE CHAIN
2
7.52
1.10
114.20
121.72
A
A
A
CA
CB
SG
CYS
CYS
CYS
14
14
14
N
4
8.43
1.10
114.20
122.63
A
A
A
CA
CB
SG
CYS
CYS
CYS
14
14
14
N
9
7.29
1.10
114.20
121.49
A
A
A
CA
CB
SG
CYS
CYS
CYS
6
6
6
N
9
7.01
1.10
114.20
121.21
A
A
A
CA
CB
SG
CYS
CYS
CYS
14
14
14
N
10
7.08
1.10
114.20
121.28
A
A
A
CA
CB
SG
CYS
CYS
CYS
14
14
14
N
11
6.83
1.10
114.20
121.03
A
A
A
CA
CB
SG
CYS
CYS
CYS
14
14
14
N
17
7.24
1.10
114.20
121.44
A
A
A
CA
CB
SG
CYS
CYS
CYS
14
14
14
N
20
7.58
1.10
114.20
121.78
A
A
A
CA
CB
SG
CYS
CYS
CYS
14
14
14
N
1
A
CYS
16
-143.14
-63.06
1
A
ASP
33
153.09
34.87
1
A
SER
50
61.19
144.58
3
A
GLU
8
-176.12
145.80
3
A
CYS
16
-109.94
-63.72
3
A
SER
32
-101.35
69.96
3
A
GLN
49
-48.87
158.04
3
A
SER
50
-150.28
67.11
4
A
CYS
16
-95.23
-64.43
4
A
SER
32
-144.34
43.22
4
A
ASP
33
170.27
37.04
4
A
GLU
43
-170.21
147.35
4
A
SER
50
65.45
168.80
5
A
SER
50
67.23
91.16
6
A
CYS
16
-131.14
-63.76
6
A
SER
50
-101.33
-60.72
7
A
CYS
16
-142.07
-64.15
7
A
ASP
33
95.75
73.44
8
A
SER
32
-157.45
72.31
9
A
CYS
16
-131.90
-68.40
9
A
GLU
43
68.49
144.95
9
A
SER
50
74.09
151.56
10
A
CYS
16
-106.94
-63.36
10
A
SER
32
-143.67
42.09
10
A
ASP
33
160.09
28.38
10
A
GLU
43
42.11
83.75
11
A
THR
7
-134.45
-39.21
11
A
LEU
13
71.38
38.50
11
A
CYS
16
-120.69
-63.98
11
A
SER
32
-101.83
67.67
12
A
CYS
16
-127.66
-62.93
13
A
LEU
13
74.73
53.36
13
A
CYS
16
-139.21
-63.24
13
A
ASP
33
38.74
67.39
13
A
GLU
43
58.50
144.90
13
A
GLN
49
-44.24
151.53
14
A
CYS
16
-107.32
-63.17
14
A
LEU
30
-69.73
73.91
14
A
ASP
33
49.63
28.02
14
A
SER
50
67.48
-75.64
15
A
CYS
16
-127.64
-63.64
15
A
ASP
33
152.89
28.42
15
A
GLU
43
72.06
83.51
15
A
SER
50
-172.93
-64.77
16
A
CYS
16
-138.89
-63.20
16
A
SER
32
-176.38
94.61
16
A
GLU
43
73.68
154.97
16
A
SER
50
63.64
162.15
17
A
LEU
15
-57.68
108.88
17
A
CYS
16
-99.18
-63.15
17
A
ASP
33
164.07
49.72
17
A
LYS
47
-50.77
108.23
18
A
THR
7
-141.35
28.00
18
A
CYS
16
-142.31
-64.57
18
A
ASP
33
78.05
61.76
18
A
SER
50
67.86
174.46
19
A
CYS
16
-123.07
-63.43
19
A
ASP
33
87.38
61.49
20
A
CYS
16
-140.84
-63.94
20
A
SER
50
-163.58
-41.57
THE NMR SOLUTION STRUCTURE OF HIRUDIN(1-51) AND COMPARISON WITH CORRESPONDING THREE-DIMENSIONAL STRUCTURES DETERMINED USING THE COMPLETE 65-RESIDUE HIRUDIN POLYPEPTIDE CHAIN
1
Y
N
disulf
2.067
A
CYS
6
A
SG
CYS
6
1_555
A
CYS
14
A
SG
CYS
14
1_555
disulf
2.162
A
CYS
16
A
SG
CYS
16
1_555
A
CYS
28
A
SG
CYS
28
1_555
disulf
2.088
A
CYS
22
A
SG
CYS
22
1_555
A
CYS
39
A
SG
CYS
39
1_555
HIRUDIN
HIRUDIN
ITH1_HIRME
UNP
1
1
P01050
VVYTDCTESGQNLCLCEGSNVCGQGNKCILGSDGEKNQCVTGEGTPKPQSHNDGDFEEIPEEYLQ
1
51
1HIC
1
51
P01050
A
1
1
51
2
2
anti-parallel
anti-parallel
A
CYS
14
A
CYS
14
A
CYS
16
A
CYS
16
A
ASN
20
A
ASN
20
A
CYS
22
A
CYS
22
A
LYS
27
A
LYS
27
A
GLY
31
A
GLY
31
A
LYS
36
A
LYS
36
A
VAL
40
A
VAL
40
1
P 1